X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs PFIZER - Comparison Results

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE PFIZER SUVEN LIFE/
PFIZER
 
P/E (TTM) x 16.0 33.3 48.0% View Chart
P/BV x 3.8 5.0 76.5% View Chart
Dividend Yield % 0.5 0.8 60.5%  

Financials

 SUVEN LIFE   PFIZER
EQUITY SHARE DATA
    SUVEN LIFE
Mar-17
PFIZER
Mar-17
SUVEN LIFE/
PFIZER
5-Yr Chart
Click to enlarge
High Rs2292,055 11.1%   
Low Rs1511,651 9.2%   
Sales per share (Unadj.) Rs42.7429.8 9.9%  
Earnings per share (Unadj.) Rs6.973.6 9.3%  
Cash flow per share (Unadj.) Rs8.587.4 9.8%  
Dividends per share (Unadj.) Rs1.0020.00 5.0%  
Dividend yield (eoy) %0.51.1 48.8%  
Book value per share (Unadj.) Rs52.4528.7 9.9%  
Shares outstanding (eoy) m127.2845.75 278.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.44.3 103.1%   
Avg P/E ratio x27.725.2 110.1%  
P/CF ratio (eoy) x22.221.2 104.9%  
Price / Book Value ratio x3.63.5 103.3%  
Dividend payout %14.627.2 53.7%   
Avg Mkt Cap Rs m24,15884,777 28.5%   
No. of employees `0001.02.8 35.8%   
Total wages/salary Rs m5223,039 17.2%   
Avg. sales/employee Rs Th5,349.76,925.9 77.2%   
Avg. wages/employee Rs Th513.51,070.4 48.0%   
Avg. net profit/employee Rs Th858.11,186.3 72.3%   
INCOME DATA
Net Sales Rs m5,43519,663 27.6%  
Other income Rs m2111,012 20.9%   
Total revenues Rs m5,64620,674 27.3%   
Gross profit Rs m1,2913,491 37.0%  
Depreciation Rs m214629 34.0%   
Interest Rs m5710 591.7%   
Profit before tax Rs m1,2313,864 31.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m01,304 0.0%   
Tax Rs m3591,801 19.9%   
Profit after tax Rs m8723,368 25.9%  
Gross profit margin %23.717.8 133.7%  
Effective tax rate %29.246.6 62.6%   
Net profit margin %16.017.1 93.7%  
BALANCE SHEET DATA
Current assets Rs m4,91720,789 23.7%   
Current liabilities Rs m1,1867,870 15.1%   
Net working cap to sales %68.665.7 104.5%  
Current ratio x4.12.6 156.9%  
Inventory Days Days6260 104.0%  
Debtors Days Days3122 137.3%  
Net fixed assets Rs m3,1549,175 34.4%   
Share capital Rs m127458 27.8%   
"Free" reserves Rs m6,54323,731 27.6%   
Net worth Rs m6,67024,189 27.6%   
Long term debt Rs m25925 1,037.2%   
Total assets Rs m8,15732,706 24.9%  
Interest coverage x22.7403.5 5.6%   
Debt to equity ratio x00 3,761.4%  
Sales to assets ratio x0.70.6 110.8%   
Return on assets %11.410.3 110.2%  
Return on equity %13.113.9 93.9%  
Return on capital %18.621.4 86.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m4,99663 7,943.2%   
Fx outflow Rs m9594,067 23.6%   
Net fx Rs m4,037-4,004 -100.8%   
CASH FLOW
From Operations Rs m1,0883,288 33.1%  
From Investments Rs m-3,107-2,496 124.5%  
From Financial Activity Rs m-300-826 36.3%  
Net Cashflow Rs m-2,319-35 6,701.2%  

Share Holding

Indian Promoters % 63.4 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 0.0 7.5 -  
FIIs % 0.0 4.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 23.7 154.0%  
Shareholders   37,287 85,207 43.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   CIPLA  SANOFI INDIA  ALKEM LABORATORIES  SHASUN PHARMA  PIRAMAL ENTERPRISES  

Compare SUVEN LIFE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 219 Points Lower; Energy and Auto Stocks Witness Selling(Closing)

After witnessing volatile trades during the day, Indian share markets ended their session on a negative note. Losses were largely seen in the oil & gas sector, auto sector.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

This Behaviour is Injurious to Wealth Building(Sector Info)

Jun 13, 2018

Blindly following the herd can be the biggest wealth destroyer.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Jun 25, 2018 03:35 PM

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE - CADILA HEALTHCARE COMPARISON

COMPARE SUVEN LIFE WITH

MARKET STATS